| OLP | Oral lichen planus |
| CP | Calprotectin |
| sCP | Serum calprotectin |
| OLP-DAS | Oral Lichen Planus Disease Activity Scale |
| CRP | C-reactive protein |
| ESR | Erythrocyte sedimentation rate |
| LDH | Lactate dehydrogenase |
| AUC | Area under the curve |
| HLA | Human leukocyte antigen |
| MMP | Matrix metalloproteinase |
| EBV | Epstein–Barr virus |
| VZV | Varicella zoster virus |
| HHV | Human herpesvirus |
| HPV | Human papillomavirus |
| HCV | Hepatitis C virus |
| DM | Diabetes mellitus |
| IBD | Inflammatory bowel disease |
| WHO | World Health Organization |
| AAOMP | American Academy of Oral and Maxillofacial Pathology |
| OLR | Oral lichenoid reaction |
| OPMD | Oral potentially malignant disorder |
| ODSS | Oral Disease Severity Score |
| REU | Reticular-Erythema-Ulcerative |
| DAMP | Damage-associated molecular pattern |
| fCP | Faecal calprotectin |
| IBS | Irritable bowel syndrome |
| NSAID | Non-steroidal anti-inflammatory drug |
| DMARD | Disease-modifying antirheumatic drug |
| G-CSF | Granulocyte colony-stimulating factor |
| LP | Lichen planus |
| PETIA | Particle-enhanced turbidimetric immunoassay |
| OLP-IGA | Oral Lichen Planus-Investigator Global Assessment |
| OLP-SI | Oral Lichen Planus-Severity Index |
| OLP-SS | Oral Lichen Planus-Sign Score |
| NRS | Numerical rating scale |
| ANOVA | Analysis of variance |
| SD | Standard deviation |
| IQR | Interquartile range |
| N | Number |
| M | Male |
| F | Female |
| ROC | Receiver Operating Characteristic curve |
| GI | Gastrointestinal |
| Lkc | Leukocyte |
| IL-6 | Interleukin 6 |